DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy

References

• PovedaASalazarRdel CampoJMUpdate in the management of ovarian and cervical carcinomaClin Transl Oncol20079744345117652058
   PubMed Web of Science ®Google Scholar
• Muñoz-CasaresFCMedina-FernándezFJArjona-SánchezÁPeritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: long-term outcomes and perspectives from a high-volume centerEur J Surg Oncol201642222423326673283
   PubMed Web of Science ®Google Scholar
• JemalATiwariRCMurrayTAmerican Cancer SocietyCancer statistics, 2004CA Cancer J Clin200454182914974761
   PubMed Web of Science ®Google Scholar
• WebbPMJordanSJEpidemiology of epithelial ovarian cancerBest Pract Res Clin Obstet Gynaecol20174131427743768
   PubMed Web of Science ®Google Scholar
• PalomarANanniCCastellucciPValue of FDG PET/CT in patients with treated ovarian cancer and raised CA125 serum levelsMol Imaging Biol201214112312921240639
   PubMedGoogle Scholar
• FagottiAGallottaVRomanoFPeritoneal carcinosis of ovarian originWorld J Gastrointest Oncol20102210210821160928
   PubMedGoogle Scholar
• JaabackKJohnsonNLawrieTAIntraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancerCochrane Database Syst Rev20161CD00534026755441
   PubMedGoogle Scholar
• SagaeSBerekJSFuYSChangNDauplatJHackerNFPeritoneal cytology of ovarian cancer patients receiving intraperitoneal therapy: quantitation of malignant cells and responseObstet Gynecol19887257827883173930
   PubMedGoogle Scholar
• VaseyPAResistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategiesBr J Cancer200389Suppl 3S23S2814661043
   PubMed Web of Science ®Google Scholar
• TanakaKHirotaTChromosomal instability: a common feature and a therapeutic target of cancerBiochim Biophys Acta201618661647527345585
   PubMed Web of Science ®Google Scholar
• FangXZhangPAneuploidy and tumorigenesisSemin Cell Dev Biol201122659560121392584
   PubMed Web of Science ®Google Scholar
• FengYCYangJLiuCMChengZZHuangYCDNA ploidy of cervical epithelial cells should be a cure criterion of high-risk HPV infection in Xinjiang Uygur womenOnco Targets Ther2015882783325926744
   PubMed Web of Science ®Google Scholar
• RajagopalanHLengauerCAneuploidy and cancerNature2004432701533834115549096
   PubMed Web of Science ®Google Scholar
• KolfschotenGMHulscherTMPinedoHMBovenEDrug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenograftsBr J Cancer200083792192710970695
   PubMedGoogle Scholar
• KareliaNHPatelDDDesaiNSPrognostic significance of DNA aneuploidy and p21 ras oncoprotein expression in colorectal cancer and their role in the determination of treatment modalitiesInt J Biol Markers20011629710411471902
   PubMedGoogle Scholar
• VindeløvLLChristensenIJNissenNIA detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysisCytometry1983353233276188586
   PubMedGoogle Scholar
• DarzynkiewiczZCritical aspects in analysis of cellular DNA contentCurr Protoc Cytom2011 Chapter 7: Unit 7.2
   PubMedGoogle Scholar
• SmetsLASlaterRvan WeringERDNA index and %S-phase cells determined in acute lymphoblastic leukemia of children: a report from studies ALL V, ALL VI, and ALL VII (1979–1991) of the Dutch Childhood Leukemia Study Group and The Netherlands Workgroup on Cancer Genetics and CytogeneticsMed Pediatr Oncol19952564374447565305
   PubMedGoogle Scholar
• TsurusawaMKatanoNFujimotoTPrognosis and DNA aneuploidy in children with acute lymphoblastic leukemiaHaematol Blood Transfus1990331741812323631
   PubMedGoogle Scholar
• BezićJSamija-ProjićIProjićPNear-diploid hyperploidy in early breast cancer (T1a,b) is associated with higher risk of lymph node involvementPathol Oncol Res2013191717722927063
   PubMedGoogle Scholar
• HaroskeGGiroudFReithABöckingA1997 ESACP consensus report on diagnostic DNA image cytometry. Part I: basic considerations and recommendations for preparation, measurement and interpretation. European Society for Analytical Cellular PathologyAnal Cell Pathol199817418920010391371
   PubMedGoogle Scholar
• DuigouFHerlinPMarnayJMichelsJJVariation of flow cytometric DNA measurement in 1,485 primary breast carcinomas according to guidelines for DNA histogram interpretationCytometry2000421354210679741
   PubMedGoogle Scholar
• ArientiCTeseiAVerdecchiaGMPeritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapyJ Transl Med201199421689426
   PubMedGoogle Scholar
• SkehanPStorengRScudieroDNew colorimetric cytotoxicity assay for anticancer-drug screeningJ Natl Cancer Inst19908213110711122359136
   PubMed Web of Science ®Google Scholar
• ArientiCTeseiAVerdecchiaGMRole of conventional chemosensitivity test and tissue biomarker expression in predicting response to treatment of peritoneal carcinomatosis from colon cancerClin Colorectal Cancer201312212212723332421
   PubMedGoogle Scholar
• SiegelSNonparametric StatisticsLondonMcGraw-Hill Ltd.1956
   Google Scholar
• DuesbergPFabariusAHehlmannRAneuploidy, the primary cause of the multilateral genomic instability of neoplastic and preneoplastic cellsIUBMB Life2004562658115085930
   PubMedGoogle Scholar
• SansregretLSwantonCThe role of aneuploidy in cancer evolutionCold Spring Harb Perspect Med201771118
   Web of Science ®Google Scholar
• DanielsenHEPradhanMNovelliMRevisiting tumour aneuploidy – the place of ploidy assessment in the molecular eraNat Rev Clin Oncol201613529130426598944
   PubMedGoogle Scholar
• ColeyHMSargentJMTitleyJTaylorCGLack of prognostic significance of ploidy and S-phase measurements in advanced ovarian cancerAnticancer Res1999193A2111211610470157
   PubMedGoogle Scholar
• ErmiahEBuhmeidaAAbdallaFPrognostic value of proliferation markers: immunohistochemical ki-67 expression and cytometric s-phase fraction of women with breast cancer in LibyaJ Cancer2012342143123074382
   PubMedGoogle Scholar
• KimmigRWimbergerPHillemannsPKapsnerTCaspariCHeppHMultivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cellsGynecol Oncol2002841213111748971
   PubMedGoogle Scholar
• JakobsenABichelPPloidy level, histopathological differentiation and response to chemotherapy in serious ovarian cancerEur J Cancer Clin Oncol19892511158915932591451
   PubMedGoogle Scholar
• BresciaRJBarakatRABellerUThe prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovaryCancer19906511411472293860
   PubMedGoogle Scholar
• KigawaJMinagawaYIshiharaHKanamoriYTerakawaNTumor DNA ploidy and prognosis of patients with serous cystadenocarcinoma of the ovaryCancer19937238048088334634
   PubMedGoogle Scholar
• BlagdenSPHarnessing pandemonium: the clinical implications of tumor heterogeneity in ovarian cancerFront Oncol2015514926175968
   PubMed Web of Science ®Google Scholar
• HietanenPBlomqvistCWaseniusVMNiskanenEFranssilaKNordlingSDo DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?Br J Cancer1995715102910327734295
   PubMedGoogle Scholar
• SchmidtRAConradEU3rdCollinsCRabinovitchPFinneyAMeasurement and prediction of the short-term response of soft tissue sarcomas to chemotherapyCancer1993729259326018402481
   PubMed Web of Science ®Google Scholar
• TürkölmezKBaltaciSBedükYMüftüoğluYZGöğüşODNA ploidy and S-phase fraction as predictive factors of response and outcome following neoadjuvant methotrexate, vinblastine, epirubicin and cisplatin (M-VEC) chemotherapy for invasive bladder cancerScand J Urol Nephrol2002361465112002357
   PubMed Web of Science ®Google Scholar
• KarlssonMJungneliusUAamdalSCorrelation of DNA ploidy and S-phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanomaInt J Cancer1996651158543385
   PubMedGoogle Scholar
• RaspagliesiFKusamuraSCampos TorresJCCytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: the experience of National Cancer Institute of MilanEur J Surg Oncol200632667167516621425
   PubMed Web of Science ®Google Scholar
• SwantonCNickeBSchuettMChromosomal instability determines taxane responseProc Natl Acad Sci U S A2009106218671867619458043
   PubMed Web of Science ®Google Scholar